Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnets may ease stroke shoulder pain

NCT ID NCT04894097

Symptom relief Sponsor: Delta University for Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested if magnetic therapy can help with shoulder pain and movement in people who had a stroke. Fifty participants with mild muscle tightness and shoulder pain received the treatment. Researchers used ultrasound to check shoulder changes and measured pain and function. The goal was to see if magnets could be a simple, drug-free way to improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
magnetic therapy device
What this could lead to
If it works, this could offer a non-drug option for easing shoulder pain and improving movement in stroke survivors.
What could go wrong
This is a small, completed trial with only 50 people. Results may not apply to everyone, and the benefits might be modest or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Aug 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient's age was between 40 to 50 years old with 2. mild spasticity (grade 1, +1) according to modified Ashworth scale (MAS) 3. All conducted patients experienced a single stroke more than six months with cognitive capacity that enables them to comprehend and follow the instructions (Mini-Mental Scale score \> 24). Exclusion Criteria: * history of shoulder pain, trauma, or surgery before the stroke; current treatment with warfarin and an international normalized ratio greater than 4.0; use of oral non steroidal anti inflammatory drugs within 3 days before enrolment; or intra articular injections within the previous month. Patients who were unable to report their pain intensity, those with a cardiac pacemaker, and those with clinically significant osteoporosis were also excluded

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiplegia

Contacts and locations

Locations

  • Cairo university

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.